Saferon – Glenmark Pharmaceuticals

Registered App ID 2981695 Class 5 Word

Trademark information

IP India · live record
Application ID
2981695
Status
Registered
Sub status
—
Date of application
10 June 2015
Classes
5
Type
Word
Proprietor
Glenmark Pharmaceuticals Public B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai 400026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage, Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
Branch Office
IP office
Mumbai
Used since
22 July 2002
Valid / upto
10 June 2025

Goods & services

Class 5

Class 5MEDICINAL, PHARMACEUTICAL AND AYURVEDIC PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS

PR details

GLENMARK PHARMACEUTICALS LTD., B/2, MAHALAXMI CHAMBERS, 22, BHULABHAI DESAI ROAD, MUMBAI-400026, A COMPANY REGISTERED UNDER THE COMPANIES ACT, 1956, MANUFACTURERS AND TRADING MERCHANTS, (Body Incorporate)

Uploaded documents

Sign in to open
1 Additional Representation Sheet 10 Jun 2015
1 Authorization Document (POA) 10 Jun 2015
2 TM-1 10 Jun 2015
3 Additional Representation Sheet 10 Jun 2015
3 Authorization Document (POA) 10 Jun 2015
4 Reply to Exam Report (MIS-R) 28 Feb 2016
5 Journal Copy 13 Aug 2018
6 TM-O(NOTICE OF OPPOSITION) 30 Oct 2018
7 Order 14 Jan 2020
8 Certificate 27 Jan 2020
9 TM-R(RENEWAL OF TRADE MARK) 21 May 2025

Correspondence and notices

1 Hearing Notice (Show Cause) 6406951 · 2935799 24 May 2018
2 Tribunal Accepted Notice for : 2981695 6612262 · 2948367 04 Jul 2018
3 Opposition Notice 7413397 · 3536752 05 Dec 2018
4 Opposition Counter Statement 7888593 · 3853212 02 Mar 2019
5 O3 NOTICE 19704410 · 7129932 14 Feb 2025

Frequently asked questions

Saferon was applied for on 10 June 2015.

The application was filed by Glenmark Pharmaceuticals.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Saferon is 2981695.

Trademark attorney Vishesh And Associates.